Nektar Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Trade Nektar Therapeutics 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About NKTR
Nektar Therapeutics is a biotechnology company, which engages in the discovery and development of novel therapies which selectively modulate the immune system to treat autoimmune disorders. It also focuses on immunology and unparalleled expertise in polymer chemistry to create one-of-a-kind, highly-selective medicines with optimal therapeutic benefit.
CEOHoward W. Robin
CEOHoward W. Robin
Employees61
Employees61
HeadquartersSan Francisco, California
HeadquartersSan Francisco, California
Founded1990
Founded1990
Employees61
Employees61
NKTR Key Statistics
Market cap733.31M
Market cap733.31M
Price-Earnings ratio-4.55
Price-Earnings ratio-4.55
Dividend yield—
Dividend yield—
Average volume744.68K
Average volume744.68K
High today$37.69
High today$37.69
Low today$35.70
Low today$35.70
Open price$35.95
Open price$35.95
Volume609.60K
Volume609.60K
52 Week high$66.92
52 Week high$66.92
52 Week low$6.48
52 Week low$6.48
Stock Snapshot
With a market cap of 733.31M, Nektar Therapeutics(NKTR) trades at $35.75. The stock has a price-to-earnings ratio of -4.55.
On 2026-01-15, Nektar Therapeutics(NKTR) stock moved within a range of $35.70 to $37.69. With shares now at $35.75, the stock is trading +0.1% above its intraday low and -5.2% below the session's peak.
Trading volume for Nektar Therapeutics(NKTR) stock has reached 609.6K, versus its average volume of 744.68K.
Over the past 52 weeks, Nektar Therapeutics(NKTR) stock has traded between a high of $66.92 and a low of $6.48.
Over the past 52 weeks, Nektar Therapeutics(NKTR) stock has traded between a high of $66.92 and a low of $6.48.
Analyst ratings
89%
of 9 ratingsBuy
88.9%
Hold
11.1%
Sell
0%
People also own
Based on the portfolios of people who own NKTR. This list is generated using Robinhood data, and it’s not a recommendation.